SPDR S&P Biotech ETF $XBI Shares Sold by Founders Financial Securities LLC

Founders Financial Securities LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,034 shares of the exchange traded fund’s stock after selling 4,390 shares during the period. Founders Financial Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $4,578,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP purchased a new position in SPDR S&P Biotech ETF in the second quarter worth about $19,270,000. Ayalon Insurance Comp Ltd. boosted its holdings in shares of SPDR S&P Biotech ETF by 71.9% in the third quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock worth $15,074,000 after buying an additional 40,000 shares during the last quarter. Continuum Advisory LLC grew its position in shares of SPDR S&P Biotech ETF by 389.1% during the 2nd quarter. Continuum Advisory LLC now owns 18,013 shares of the exchange traded fund’s stock valued at $2,851,000 after acquiring an additional 14,330 shares during the period. Syon Capital LLC grew its stake in shares of SPDR S&P Biotech ETF by 67.9% during the 2nd quarter. Syon Capital LLC now owns 23,562 shares of the exchange traded fund’s stock valued at $3,729,000 after acquiring an additional 9,530 shares during the period. Finally, TD Waterhouse Canada Inc. increased its stake in shares of SPDR S&P Biotech ETF by 535.1% in the second quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock worth $824,000 after purchasing an additional 4,436 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $157.79 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $106.30 and a fifty-two week high of $169.89. The company has a fifty day moving average of $156.75 and a 200 day moving average of $141.41. The stock has a market capitalization of $10.69 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.